Digital Technology Interventions for Risk Factor Modification in Patients With Cardiovascular Disease: Systematic

Adewale Samuel Akinosun1, Rob Polson2, Yohanca Diaz-Skeete3

  • 1Department of Nursing and Midwifery, Institute of Health Research and Innovation, Centre for Health Science, University of the Highlands and Islands, Inverness, United Kingdom.

Insights

Digital technology interventions show promise for improving cardiovascular disease (CVD) risk factors like cholesterol and physical activity. However, they did not significantly impact weight, blood pressure, or smoking cessation in this review.

Area of Science:

  • Cardiology
  • Digital Health
  • Behavioral Science

Background:

  • Cardiovascular disease (CVD) is significantly influenced by lifestyle risk factors, yet many patients struggle to modify them.
  • Digital technology interventions are emerging as potential alternatives to traditional cardiac rehabilitation.
  • The clinical effectiveness of digital interventions for individual behavior change in CVD patients remains largely unknown.

Purpose of the Study:

  • To systematically review and meta-analyze randomized controlled trials (RCTs) evaluating digital technology interventions for CVD.
  • To identify effective behavior change constructs within these interventions for risk factor modification.

Main Methods:

  • A systematic review and meta-analysis adhering to PRISMA guidelines.
  • Quantitative analysis of mixed data from selected research databases, focusing exclusively on RCTs.
  • Statistical significance set at a 95% confidence interval and P=.05.

Main Results:

  • Digital interventions significantly improved total cholesterol, HDL, LDL, physical activity, and reduced sedentary behavior and unhealthy food intake.
  • No significant benefits were observed for body mass index (BMI), diastolic blood pressure (BP), systolic BP, HbA1c, alcohol intake, smoking, or medication adherence.

Conclusions:

  • Digital interventions show potential for enhancing healthy behaviors such as physical activity and diet in CVD patients.
  • These interventions may be more effective when targeting multiple behavioral outcomes simultaneously.
  • Current evidence does not support the effectiveness of digital interventions in reducing unhealthy behaviors like smoking or improving key clinical outcomes such as BMI and blood pressure.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
111
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
474
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
653
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
121
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
110
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
276